FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288046151> ?p ?o ?g. }

• W4288046151 abstract "Abstract Arterial calcification is highly prevalent, particularly in patients with end-stage renal disease (ESRD). The osteogenic differentiation of vascular smooth muscle cells (VSMCs) is the critical process for the development of arterial calcification. However, the detailed mechanism of VSMCs calcification remains to be elucidated. Here, we investigated the role of exosomes (Exos) derived from endothelial cells (ECs) in arterial calcification and its potential mechanisms in ESRD. Accelerated VSMCs calcification was observed when VSMCs were exposed to ECs culture media stimulated by uremic serum or high concentration of inorganic phosphate (3.5 mM Pi). and the pro-calcification effect of the ECs culture media was attenuated by exosome depletion. Exosomes derived from high concentrations of inorganic phosphate-induced ECs (ECs HPi -Exos) could be uptaken by VSMCs and promoted VSMCs calcification. Microarray analysis showed that miR-670-3p was dramatically increased in ECs HPi -Exos compared with exosomes derived from normal concentrations of inorganic phosphate (0.9 mM Pi) induced ECs (ECs NPi -Exos). Mechanistically, insulin-like growth factor 1 (IGF-1) was identified as the downstream target of miR-670-3p in regulating VSMCs calcification. Notably, ECs-specific knock-in of miR-670-3p of the 5/6 nephrectomy with a high-phosphate diet (miR-670-3p EC-KI + NTP) mice that upregulated the level of miR-670-3p in artery tissues and significantly increased artery calcification. Finally, we validated that the level of circulation of plasma exosomal miR-670-3p was much higher in patients with ESRD compared with healthy controls. Elevated levels of plasma exosomal miR-670-3p were associated with a decline in IGF-1 and more severe artery calcification in patients with ESRD. Collectively, these findings suggested that ECs-derived exosomal miR-670-3p could promote arterial calcification by targeting IGF-1, which may serve as a potential therapeutic target for arterial calcification in ESRD patients." @default.
• W4288046151 created "2022-07-27" @default.
• W4288046151 creator A5000732161 @default.
• W4288046151 creator A5004478662 @default.
• W4288046151 creator A5005482797 @default.
• W4288046151 creator A5006589921 @default.
• W4288046151 creator A5009017282 @default.
• W4288046151 creator A5016644387 @default.
• W4288046151 creator A5020523415 @default.
• W4288046151 creator A5025857039 @default.
• W4288046151 creator A5031843349 @default.
• W4288046151 creator A5032673492 @default.
• W4288046151 creator A5035376592 @default.
• W4288046151 creator A5051564024 @default.
• W4288046151 creator A5055105005 @default.
• W4288046151 creator A5058703113 @default.
• W4288046151 creator A5078056887 @default.
• W4288046151 creator A5078081440 @default.
• W4288046151 creator A5080267086 @default.
• W4288046151 creator A5087647739 @default.
• W4288046151 date "2022-07-26" @default.
• W4288046151 modified "2023-10-14" @default.
• W4288046151 title "The crosstalk between endothelial cells and vascular smooth muscle cells aggravates high phosphorus-induced arterial calcification" @default.
• W4288046151 cites W1954145299 @default.
• W4288046151 cites W1982471919 @default.
• W4288046151 cites W2012380963 @default.
• W4288046151 cites W2014346055 @default.
• W4288046151 cites W2026880762 @default.
• W4288046151 cites W2029341317 @default.
• W4288046151 cites W2042256973 @default.
• W4288046151 cites W2054637102 @default.
• W4288046151 cites W2057971268 @default.
• W4288046151 cites W2071054065 @default.
• W4288046151 cites W2072456944 @default.
• W4288046151 cites W2100149565 @default.
• W4288046151 cites W2109390099 @default.
• W4288046151 cites W2114164409 @default.
• W4288046151 cites W2118793476 @default.
• W4288046151 cites W2128298292 @default.
• W4288046151 cites W2139545658 @default.
• W4288046151 cites W2145073188 @default.
• W4288046151 cites W2147834547 @default.
• W4288046151 cites W2151948534 @default.
• W4288046151 cites W2154209069 @default.
• W4288046151 cites W2155645904 @default.
• W4288046151 cites W2159616443 @default.
• W4288046151 cites W2162625952 @default.
• W4288046151 cites W2165719798 @default.
• W4288046151 cites W2169883083 @default.
• W4288046151 cites W2185246112 @default.
• W4288046151 cites W2215155109 @default.
• W4288046151 cites W2253658769 @default.
• W4288046151 cites W2296538017 @default.
• W4288046151 cites W2552340778 @default.
• W4288046151 cites W2559040512 @default.
• W4288046151 cites W2610664711 @default.
• W4288046151 cites W2612980975 @default.
• W4288046151 cites W2622242002 @default.
• W4288046151 cites W2763606722 @default.
• W4288046151 cites W2771711630 @default.
• W4288046151 cites W2796879501 @default.
• W4288046151 cites W2805783924 @default.
• W4288046151 cites W2810368020 @default.
• W4288046151 cites W2888776119 @default.
• W4288046151 cites W2889533658 @default.
• W4288046151 cites W2893611825 @default.
• W4288046151 cites W2905196711 @default.
• W4288046151 cites W2921455953 @default.
• W4288046151 cites W2945126542 @default.
• W4288046151 cites W2952187953 @default.
• W4288046151 cites W2958200004 @default.
• W4288046151 cites W2972563189 @default.
• W4288046151 cites W2973026699 @default.
• W4288046151 cites W2999901765 @default.
• W4288046151 cites W3011621398 @default.
• W4288046151 cites W3126342051 @default.
• W4288046151 cites W3137607816 @default.
• W4288046151 cites W3156589201 @default.
• W4288046151 doi "https://doi.org/10.1038/s41419-022-05064-5" @default.
• W4288046151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35882857" @default.
• W4288046151 hasPublicationYear "2022" @default.
• W4288046151 type Work @default.
• W4288046151 citedByCount "13" @default.
• W4288046151 countsByYear W42880461512022 @default.
• W4288046151 countsByYear W42880461512023 @default.
• W4288046151 crossrefType "journal-article" @default.
• W4288046151 hasAuthorship W4288046151A5000732161 @default.
• W4288046151 hasAuthorship W4288046151A5004478662 @default.
• W4288046151 hasAuthorship W4288046151A5005482797 @default.
• W4288046151 hasAuthorship W4288046151A5006589921 @default.
• W4288046151 hasAuthorship W4288046151A5009017282 @default.
• W4288046151 hasAuthorship W4288046151A5016644387 @default.
• W4288046151 hasAuthorship W4288046151A5020523415 @default.
• W4288046151 hasAuthorship W4288046151A5025857039 @default.
• W4288046151 hasAuthorship W4288046151A5031843349 @default.
• W4288046151 hasAuthorship W4288046151A5032673492 @default.
• W4288046151 hasAuthorship W4288046151A5035376592 @default.
• W4288046151 hasAuthorship W4288046151A5051564024 @default.
• W4288046151 hasAuthorship W4288046151A5055105005 @default.
• W4288046151 hasAuthorship W4288046151A5058703113 @default.

• next